Adirondack Research & Management’s AbbVie ABBV Stock Holding History

Adirondack Research & Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$204K	Hold	1,890	–	–	0.25%	97
2021 Q2	$213K	Hold	1,890	–	–	0.25%	91
2021 Q1	$205K	Hold	1,890	–	–	0.24%	88
2020 Q4	$203K	Buy	+1,890	New	+$182K	0.28%	76
2018 Q1	–	Sell	-4,100	Closed	-$397K	–	113
2017 Q4	$397K	Sell	4,100 -2,200	-35%	-$207K	0.16%	95
2017 Q3	$560K	Hold	6,300	–	–	0.22%	77
2017 Q2	$457K	Hold	6,300	–	–	0.18%	84
2017 Q1	$411K	Hold	6,300	–	–	0.15%	94
2016 Q4	$395K	Hold	6,300	–	–	0.13%	91
2016 Q3	$397K	Hold	6,300	–	–	0.14%	92
2016 Q2	$390K	Hold	6,300	–	–	0.15%	92
2016 Q1	$360K	Hold	6,300	–	–	0.13%	91
2015 Q4	$373K	Hold	6,300	–	–	0.14%	85
2015 Q3	$343K	Hold	6,300	–	–	0.13%	91
2015 Q2	$423K	Sell	6,300 -125	-2%	-$8.16K	0.16%	84
2015 Q1	$376K	Hold	6,425	–	–	0.15%	84
2014 Q4	$420K	Sell	6,425 -50	-0.8%	-$3.15K	0.16%	85
2014 Q3	$374K	Hold	6,475	–	–	0.14%	90
2014 Q2	$365K	Hold	6,475	–	–	0.12%	93
2014 Q1	$333K	Hold	6,475	–	–	0.13%	93
2013 Q4	$342K	Hold	6,475	–	–	0.17%	89
2013 Q3	$290K	Sell	6,475 -200	-3%	-$8.87K	0.17%	90
2013 Q2	$276K	Buy	+6,675	New	+$292K	0.21%	90

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Adirondack Research & Management's ABBV Position: Q3 2021 in Review

Adirondack Research & Management held its AbbVie (ABBV) position steady in Q3 2021 at 1,890 shares worth $204K. The position accounts for 0.25% of the portfolio, ranked #97.

Adirondack Research & Management first reported a position in ABBV in Q2 2013 and has held it in 23 quarters since. The position peaked at $560K in Q3 2017. 2,657 funds tracked by Wall St. Rank hold ABBV as of Q3 2021.

Adirondack Research & Management held 1,890 shares of AbbVie worth $204K as of Q3 2021.
Adirondack Research & Management left its AbbVie share count unchanged in Q3 2021.
AbbVie made up 0.25% of Adirondack Research & Management's portfolio in Q3 2021, its #97 holding.
Adirondack Research & Management first reported a position in AbbVie in Q2 2013 and has held it in 23 quarters since.
Adirondack Research & Management's AbbVie position peaked at $560K in Q3 2017.
2,657 funds tracked by Wall St. Rank held AbbVie as of Q3 2021.

Based on Adirondack Research & Management's 13F filing for Q3 2021, filed 29 Oct 2021.